Current Endovascular Treatment Options in Acute Pulmonary Embolism.
Kelli MooreJeff KuninMohammed AlnijoumiPrashant NagpalAmbarish P BhatPublished in: Journal of clinical imaging science (2021)
Acute pulmonary embolism (PE) is a significant cause of mortality and morbidity across the globe. Over the last few decades, there have been major therapeutic advances in acute PE management, including catheter-based therapy. However, the effectiveness of catheter-based therapy in acute PE is not supported by Level I evidence, making the use of this promising treatment rather controversial and ambiguous. In this paper, we discuss the risk stratification of acute PE and review the medical and endovascular treatment options. We also summarize and review the data supporting the use of endovascular treatment options in acute PE and describe the potential role of the PE response team.
Keyphrases
- pulmonary embolism
- liver failure
- aortic dissection
- respiratory failure
- drug induced
- inferior vena cava
- randomized controlled trial
- healthcare
- hepatitis b virus
- systematic review
- type diabetes
- risk assessment
- palliative care
- coronary artery disease
- bone marrow
- artificial intelligence
- replacement therapy
- data analysis